- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT00024544
Pilot Study in Patients With Symptomatic Steroid-Naive Asthma
March 6, 2012 updated by: Facet Biotech
A Phase I/II, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Pilot Study of SB 240683 in Patients With Symptomatic Steroid-Naive Asthma
The purpose of the study is to evaluate an investigational medication to treat chronic asthma.
The research is being conducted at 20 clinical research sites in the US and is open to both men and women ages 18 to 70 years.
Participants in the study will have a number of visits to a research site over an 8-month period.
All study-related care and medication is provided to qualified participants at no cost.
This includes all visits, examinations and laboratory work.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment
120
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
California
-
Los Angeles, California, United States, 90025
- Allergy Research Foundation
-
Mission Viejo, California, United States, 92691
- Southern California Research
-
Orange, California, United States, 92868
- Clinical Trials of Orange Cnty., Inc.
-
San Diego, California, United States, 92120
- Allergy Associates Medical Group, Inc.
-
San Jose, California, United States, 95117
- Allergy and Asthma Associates Santa Clara Valley Research Center
-
Stockton, California, United States, 95207
- Bensch Research Associates
-
-
Colorado
-
Denver, Colorado, United States, 80206
- National Jewish Medical and Research Center
-
-
Illinois
-
Normal, Illinois, United States, 61761
- ICSL Clinical Studies
-
-
Massachusetts
-
Boston, Massachusetts, United States, 02115
- Respiratory Therapy and Pulmonary Clinical Research Brigham & Women's Hospital
-
N. Dartmouth, Massachusetts, United States, 02747
- New England Clinical Studies
-
-
Minnesota
-
Minneapolis, Minnesota, United States, 55402
- Clinical Research Institute
-
-
Missouri
-
St. Louis, Missouri, United States, 63141
- The Clinical Research Center, LLC
-
-
Nebraska
-
Omaha, Nebraska, United States, 68131
- Center for Allergy, Asthma and Immunology, Creighton University
-
-
New Jersey
-
Princeton, New Jersey, United States, 08540
- Princeton Center for Clinical Research
-
-
Oregon
-
Lake Oswego, Oregon, United States, 97035
- Allergy, Asthma, and Dermatology Research Center, LLC
-
-
Pennsylvania
-
Easton, Pennsylvania, United States, 18045
- Valley Clinical Research Center
-
-
Texas
-
Houston, Texas, United States, 77090
- Clinical Trials North Houston
-
-
Wisconsin
-
Madison, Wisconsin, United States, 53792
- University of Wisconsin Medical School
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years to 70 years (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- At least a 6-month history of asthma
- No use of inhaled, oral or injectable steroids for at least 1 month prior to enrollment
Exclusion Criteria:
- Patients with > 10 pack years of smoking history or smoking within 12 months of study enrollment
- No significant disease other than asthma
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
August 1, 2001
Primary Completion (Actual)
February 1, 2003
Study Completion (Actual)
February 1, 2003
Study Registration Dates
First Submitted
September 19, 2001
First Submitted That Met QC Criteria
September 19, 2001
First Posted (Estimate)
September 20, 2001
Study Record Updates
Last Update Posted (Estimate)
March 7, 2012
Last Update Submitted That Met QC Criteria
March 6, 2012
Last Verified
March 1, 2012
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 683-803
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Asthma
-
Vanderbilt University Medical CenterNot yet recruitingAsthma in Children | Asthma Attack | Asthma Acute | Acute Asthma Exacerbation | Asthma; StatusUnited States
-
University of California, San FranciscoCompletedAsthma in Children | Asthma Attack | Asthma Acute | Asthma ChronicUnited States
-
SingHealth PolyclinicsNot yet recruitingAsthma | Asthma in Children | Asthma Attack | Asthma Acute | Asthma Chronic
-
Johann Wolfgang Goethe University HospitalCompleted
-
Parc de Salut MarActive, not recruitingAsthma in Children | Persistent Asthma | Asthma ExacerbationSpain
-
Universita di VeronaCompleted
-
Forest LaboratoriesCompleted
-
Brunel UniversityKarolinska InstitutetUnknown
-
Value Outcomes Ltd.AstraZenecaCompletedAsthma, Bronchial | Bronchial Asthma | Asthma Chronic | Asthma; EosinophilicCzechia
Clinical Trials on anti-IL-4 monoclonal antibody (pascolizumab)
-
University Hospital, BrestCompletedPolymyalgia RheumaticaFrance
-
Keymed Biosciences Co.LtdRecruiting
-
Beijing VDJBio Co., LTD.Completed
-
Shanghai Huaota Biopharmaceutical Co., Ltd.RecruitingGeneralized Pustular Psoriasis (GPP)China
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingActive Ankylosing SpondylitisChina
-
Shanghai Junshi Bioscience Co., Ltd.Sponsor GmbHRecruitingNon-radiographic Axial SpondyloarthritisChina
-
Shanghai Huaota Biopharmaceutical Co., Ltd.Completed
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Shanghai HyaMab Biotech Co.,Ltd.CompletedLocally Advanced/Metastatic Solid TumorsChina
-
AbbVie (prior sponsor, Abbott)CompletedPsoriasisUnited States, Canada